000 | 02888 a2200793 4500 | ||
---|---|---|---|
005 | 20250513112829.0 | ||
264 | 0 | _c19970310 | |
008 | 199703s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.1997.15.2.491 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVitolo, U | |
245 | 0 | 0 |
_aIntensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 1997 |
||
300 |
_a491-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
650 | 0 | 4 | _aBone Marrow Transplantation |
650 | 0 | 4 | _aCarmustine |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aEtoposide |
650 | 0 | 4 | _aFeasibility Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
650 | 0 | 4 | _aLeukapheresis |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMelphalan |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTransplantation, Autologous |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aCortellazzo, S | |
700 | 1 | _aLiberati, A M | |
700 | 1 | _aFreilone, R | |
700 | 1 | _aFalda, M | |
700 | 1 | _aBertini, M | |
700 | 1 | _aBotto, B | |
700 | 1 | _aCinieri, S | |
700 | 1 | _aLevis, A | |
700 | 1 | _aLocatelli, F | |
700 | 1 | _aLovisone, E | |
700 | 1 | _aMarmont, F | |
700 | 1 | _aPizzuti, M | |
700 | 1 | _aRossi, A | |
700 | 1 | _aViero, P | |
700 | 1 | _aBarbui, T | |
700 | 1 | _aGrignani, F | |
700 | 1 | _aResegotti, L | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 15 _gno. 2 _gp. 491-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1997.15.2.491 _zAvailable from publisher's website |
999 |
_c9041630 _d9041630 |